Details for Patent: 11,504,334
✉ Email this page to a colleague
Which drugs does patent 11,504,334 protect, and when does it expire?
Patent 11,504,334 protects DROSPIRENONE and SLYND and is included in two NDAs.
This patent has sixty-five patent family members in twenty-nine countries.
Drugs Protected by US Patent 11,504,334
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exeltis Usa Inc | DROSPIRENONE | drospirenone | TABLET, CHEWABLE;ORAL | 216285-001 | Jun 29, 2022 | DISCN | Yes | No | 11,504,334 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Exeltis Usa Inc | SLYND | drospirenone | TABLET;ORAL | 211367-001 | May 23, 2019 | AB | RX | Yes | Yes | 11,504,334 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,504,334
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2588114 | ⤷ Subscribe | CA 2020 00023 | Denmark | ⤷ Subscribe |
| European Patent Office | 2588114 | ⤷ Subscribe | 2020C/518 | Belgium | ⤷ Subscribe |
| European Patent Office | 2588114 | ⤷ Subscribe | 19/2020 | Austria | ⤷ Subscribe |
| European Patent Office | 2588114 | ⤷ Subscribe | C202030026 | Spain | ⤷ Subscribe |
| European Patent Office | 2588114 | ⤷ Subscribe | 301123 | Netherlands | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
